Effectiveness and Tolerability of Fulvestrant in Postmenopausal Women with Hormone Receptor—Positive Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference20 articles.
1. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer;Osborne;J Natl Cancer Inst,1995
2. Response to a specific antiestrogen (ICI 182780) in tamoxifen-resistant breast cancer;Howell;Lancet,1995
3. Duration of remission to ICI 182,780 compared to megestrol acetate in tamoxifen resistant breast cancer;Robertson;Breast,1997
4. Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment;Howell;J Clin Oncol,2002
5. Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial;Osborne;J Clin Oncol,2002
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models;Breast Cancer Research and Treatment;2020-02-06
2. Challenges in managing a patient with multiple primary malignancies;Community Oncology;2012-12
3. Chemotherapeutic Agents;Management of Breast Diseases;2010
4. Fulvestrant in Advanced Breast Cancer Following Tamoxifen and Aromatase Inhibition: A Single Center Experience;The Breast Journal;2009-05
5. Fulvestrant;DMW - Deutsche Medizinische Wochenschrift;2006-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3